Not Signed In -
black haw |
American Sloe; stag bush; sweet viburnum |
Clinical Trial: Black Cohosh Extract in Postmenopausal Breast Health
This study is currently recruiting patients.
|
Purpose
The purpose of the study is to determine if black cohosh extract (BCE) administration in symptomatic postmenopausal women results in estrogenic stimulation of the breast, as determined by estradiol, pS2, FSH, LH, and PSA levels in nipple aspirate fluid.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Menopause Hot Flashes | Drug: Black Cohosh Extract (BCE) | Phase I Phase II |
MedlinePlus related topics: Menopause
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: The Effect of Black Cohosh Extract on the Human Breast
Further Study Details:
Expected Total Enrollment: 73
Study start: July 2003; Expected completion: June 2005
Eligibility
Genders Eligible for Study: Female
Criteria
- Postmenopausal females
- 20 months since any breastfeeding
- Active postmenopausal symptoms, i.e., hot flashes
- At least 6 months since last menstrual period or have had a hysterectomy with both ovaries removed - Able to make 4 visits during the trial to the study clinic in Columbia, Missouri
Location and Contact Information
Jenny Haubner, RN haubnerjs@health.missouri.edu
Missouri
University of Missouri-Columbia, Columbia, Missouri, 65212, United States; Recruiting
Lisa Schlatter, RN 573-882-1895 schlatterl@health.missouri.edu
Edward Sauter, MD, PhD 573-882-4471 sautere@health.missouri.edu
Edward Sauter, MD, PhD 573-882-4471 sautere@health.missouri.edu
More Information
http://www.breastcancerlab.org
Study ID Numbers: AT 001102-01; SauterE
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: July 14, 2003
ClinicalTrials.gov Identifier: NCT00064831
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: July 14, 2003
ClinicalTrials.gov Identifier: NCT00064831
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
email this page
print this page
bookmark this page
feedback on this page
